Skip to main content

Joseph Kamel Salama

Professor of Radiation Oncology
Radiation Oncology
Box 3085, Duke University Medical Center, Durham, NC 27710
201 Trent Drive, Box 3085, Durham, NC 27710

Overview


I have the privilege to be the Chief of the Durham VA Radiation Oncology Service, where I care for veterans who have served our country. I am a dedicated educator, serving as the Residency Program Director for the Duke Radiation Oncology Residency Program.  I am also a cancer researcher developing novel treatment techniques for patients with head and neck cancer, lung cancer, prostate cancer, and those limited metastatic disease, and integration of these treatments with drug therapies.

Current Appointments & Affiliations


Professor of Radiation Oncology · 2018 - Present Radiation Oncology, Clinical Science Departments
Member of the Duke Cancer Institute · 2016 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Survival and recurrence rates following SBRT or surgery in medically operable Stage I NSCLC.

Journal Article Lung Cancer · November 2024 OBJECTIVES: Surgery is the standard of care for early-stage non-small cell lung cancer (NSCLC), with SBRT reserved for patients who are not surgical candidates. We hypothesized overall survival (OS), lung cancer-specific survival (LCSS), progression free s ... Full text Link to item Cite

Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience.

Journal Article Curr Oncol · August 21, 2024 The United States Veterans Affairs (VA) Health Care System has a strong history of conducting impactful oncology randomized clinical trials (RCTs). We developed a phase II/III RCT to test the use of metastasis-directed therapy in Veterans with oligometasta ... Full text Link to item Cite

Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course.

Journal Article Adv Radiat Oncol · June 2024 PURPOSE: Clinical and imaging surveillance of patients with brain metastases is important after stereotactic radiosurgery (SRS) because many will experience intracranial progression (ITCP) requiring multidisciplinary management. The prognostic significance ... Full text Link to item Cite
View All Publications

Recent Grants


Regulation of oncogenesis and tumor response to radiation therapy by phase separation

ResearchCo-Mentor · Awarded by American Society for Radiation Oncology · 2024 - 2025

Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung Cancer

Clinical TrialCo Investigator · Awarded by Washington University in St. Louis · 2022 - 2025

Knowledge-based Tutoring for Knowledge-based Radiation Therapy

ResearchCo Investigator · Awarded by Varian Medical Systems, Inc. · 2020 - 2022

View All Grants

Education, Training & Certifications


Baylor, College of Medicine · 2001 M.D.